Do you omit PMRT for patients who would have been eligible for NSABP B-51, but are found to have significant pure LVSI only, without stromal carcinoma, after neoadjuvant chemotherapy?
1 Answers
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network
I would treat it like a partial response and favor RT.
